Impact of time-of-day administration of immune checkpoint inhibitors on survival outcomes in patients with recurrent/metastatic head and neck cancer (R/M HNSCC): a retrospective cohort studyPaulien Van Loocke, Paul M. Clément, Robin Willaert et al.|Oral Oncology|2025Cited by 3
Primary vs. second primary cT1-T2 oral squamous cell carcinoma: comparing the outcomesNoëmi Ramirez-Guanche, Vincent Vander Poorten, Fien Jaeken et al.|Frontiers in Surgery|2025Cited by 1